Kamau Therapeutics

San Francisco, CA · Founded 2023 · Privately Held (backing)

Operator of a clinical-stage, next-generation gene correction company intended to cure serious and life-threatening diseases. Kamau Therapeutics is based in San Francisco, CA and was founded in 2023. It was valued at $48.5 million at its seed round in Jun 2025, the last priced event on record. It has raised $31.8 million across 1 recorded round; the latest was a $5 million seed round in May 2025.

PMV mark · valuation
$48.5M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$31.8M
Last round
Seed Round
May 2025
What is Kamau Therapeutics worth?
$48.5MPrivateMarketView mark · Oct 2026

Valued at $48.5M at its seed round, Jun 2025. Nothing has traded since.

Free account
More of Kamau Therapeutics with a free account
  • ·Watch Kamau Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Kamau Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
May 2025Seed Round$5.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Kamau Therapeutics valuation

Kamau Therapeutics was valued at $48.5 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Kamau Therapeutics raised?

Kamau Therapeutics has raised $31.8 million in total; 1 of its rounds is on record. The largest on record was a $5 million seed round in May 2025.

Kamau Therapeutics has filed 1 Form D with the SEC, most recently in Jun 2025 ($5 million sold to 6 investors).

How Kamau Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Kamau Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Kamau Therapeutics

What is Kamau Therapeutics worth?
Kamau Therapeutics is valued at $48.5M as of Oct 2026. Valued at $48.5M at its seed round, Jun 2025. Nothing has traded since.
How much has Kamau Therapeutics raised?
Kamau Therapeutics has raised $31.8M in total funding across 1 recorded rounds.
When did Kamau Therapeutics last raise?
Kamau Therapeutics last raised in May 2025 (Seed Round), raising $5.0M.